On the mechanism of antithrombotic action of flavonoids.

Flavonols (quercetin and rutin) and flavanes (cyanidol and meciadonol) were studied for their effect on non-enzymatic lipid peroxidation, lipoxygenase and cyclo-oxygenase activities, binding to albumin and platelet membranes. These biochemical properties of four flavonoids were compared with respect to their antithrombotic action in vivo and their efficacy at influencing the platelet-endothelium interaction in vitro. All four flavonoids inhibited the ascorbate-stimulated formation of malondialdehyde by boiled rat liver microsomes (quercetin greater than rutin approximately cyanidol approximately meciadonol) and inhibited platelet lipoxygenase activity (quercetin greater than cyanidol greater than meciadonol greater than rutin) whereas only flavonols, but not flavanes, stimulated cyclo-oxygenase and were bound to platelet membranes. The same two flavonols dispersed platelet thrombi which were adhering to the rabbit aortic endothelium in vitro (EC50 for quercetin was 80 nM and for rutin 500 nM) and prevented platelets from aggregation over blood-superfused collagen strip in vivo (ED50 for quercetin was 5 nmol/kg and for rutin 33 nmol/kg i.v.). Cyanidol and meciadonol were not effective as anti-thrombotic agents. It is concluded that activated platelets adhering to vascular endothelium generate lipid peroxides and oxygen-free radicals which inhibit endothelial biosynthesis of prostacyclin and destroy endothelium-derived relaxing factor (EDRF). Flavonols are anti-thrombotic because they are selectively bound to mural platelet thrombi and owing to their free radical scavenging properties resuscitate biosynthesis and action of endothelial prostacyclin and EDRF. Thus, flavonols release the thrombolytic and vasoprotective endothelial mediators only in these vascular segments which are covered by a carpet of aggregating platelets.

[1]  R. Gryglewski,et al.  Antioxidant properties of some chemicals vs their influence on cyclooxygenase and lipoxidase activities. , 1983, Biochemical pharmacology.

[2]  R. Gryglewski,et al.  Binding of the membrane active drugs to bovine serum albumin and human erythrocyte membranes. , 1975, Biochemical pharmacology.

[3]  K. Sekiya,et al.  Selective inhibition of platelet lipoxygenase by baicalein. , 1982, Biochemical and biophysical research communications.

[4]  A. Dembińska-kieć,et al.  Prostacyclin and thromboxane A2 biosynthesis capacities of heart, arteries and platelets at various stages of experimental atherosclerosis in rabbits. , 1978, Atherosclerosis.

[5]  L. Cavallini,et al.  Comparative evaluation of antiperoxidative action of silymarin and other flavonoids. , 1978, Pharmacological research communications.

[6]  H. Jha,et al.  Inhibition of in vitro microsomal lipid peroxidation by isoflavonoids. , 1985, Biochemical pharmacology.

[7]  D. Aharony,et al.  Regulation of arachidonate-induced platelet aggregation by the lipoxygenase product, 12-hydroperoxyeicosatetraenoic acid. , 1982, Biochimica et biophysica acta.

[8]  F. Bruchhausen,et al.  Hemmung der Prostaglandinsynthetase durch Flavonoide und Phenolderivate im Vergleich mit deren O2−•‐Radikalfänger‐eigenschaften , 1980 .

[9]  M. Steiner,et al.  Modification of platelet function and arachidonic acid metabolism by bioflavonoids. Structure-activity relations. , 1984, Biochemical pharmacology.

[10]  S. Moncada,et al.  An improved method for washing of human platelets with prostacyclin. , 1983, Thrombosis research.

[11]  W. Lands Interactions of lipid hydroperoxides with eicosanoid biosynthesis. , 1985, Journal of free radicals in biology & medicine.

[12]  J. Baumann,et al.  Flavonoids and related compounds as inhibition of arachidonic acid peroxidation. , 1980, Prostaglandins.

[13]  M. Steiner,et al.  Inhibition in vitro of platelet aggregation and arachidonic acid metabolism by flavone. , 1984, Biochemical pharmacology.

[14]  J. Robak,et al.  The influence of chlorpromazine on lipoxidases. , 1980, Biochimica et biophysica acta.

[15]  J. Vane,et al.  Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides. , 1976, Prostaglandins.

[16]  M. Ishikawa,et al.  Endothelium‐dependent inhibition of platelet aggregation , 1986, British journal of pharmacology.

[17]  R. C. Dirks,et al.  The role of lipid, free radical initiator, and oxygen on the kinetics of lipid peroxidation. , 1982, Toxicology and applied pharmacology.

[18]  S. Moncada,et al.  Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor , 1986, Nature.

[19]  A. Marcus,et al.  Superoxide production and reducing activity in human platelets. , 1977, The Journal of clinical investigation.

[20]  C. Fiedler-Nagy,et al.  In vitro inhibition of the biosynthesis of slow reacting substance of anaphylaxis (SRS-A) and lipoxygenase activity by quercetin. , 1983, Biochemical pharmacology.